Literature DB >> 17212857

Immigration medical screening and HIV infection in Canada.

M Zencovich1, K Kennedy, D W MacPherson, B D Gushulak.   

Abstract

HIV infection, particularly associated with AIDS, is often used by migrant screening nations to exclude entry into the country. The unique feature of the Canadian immigration HIV screening programme is that it was not primarily for determining inadmissibility of HIV-positive applicants, but for health promotion and disease prevention purposes. All applicants over 15 years of age for permanent residency or temporary residency from designated countries are HIV antibody tested. This includes persons seeking asylum from within Canada. The highest rates of HIV infection were found in migrant applicants from high prevalence areas of the world and reflected the demographic profile of the source region (predominately women). The majorities of HIV-positive persons are exempt from exclusion from Canada due to class of application (refugee, family) or are already in Canada (refugee claimant). Significant issues in notification, reporting and programme management have been identified as a consequence of this programme.

Entities:  

Mesh:

Year:  2006        PMID: 17212857     DOI: 10.1258/095646206779307469

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  12 in total

1.  High HIV-TB co-infection rates in marginalized populations: evidence from Alberta in support of screening TB patients for HIV.

Authors:  Richard Long; Jody Boffa
Journal:  Can J Public Health       Date:  2010 May-Jun

2.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

3.  The changing face of Canadian immigration: Implications for infectious diseases.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-07       Impact factor: 2.471

Review 4.  Health Inequity and "Restoring Fairness" Through the Canadian Refugee Health Policy Reforms: A Literature Review.

Authors:  Valentina Antonipillai; Andrea Baumann; Andrea Hunter; Olive Wahoush; Timothy O'Shea
Journal:  J Immigr Minor Health       Date:  2018-02

Review 5.  Migration Health: Highlights from Inaugural International Society of Travel Medicine (ISTM) Conference on Migration Health.

Authors:  Anita E Heywood; Francesco Castelli; Christina Greenaway
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

6.  Prevalence of selected preventable and treatable diseases among government-assisted refugees: Implications for primary care providers.

Authors:  Kevin Pottie; Praseedha Janakiram; Patricia Topp; Anne McCarthy
Journal:  Can Fam Physician       Date:  2007-11       Impact factor: 3.275

7.  The changing demographics of women living with HIV/AIDS in southern Alberta from 1982 to 2006.

Authors:  Liana Hwang; Jesse Raffa; Michael John Gill
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

8.  Emerging pediatric HIV epidemic related to migration.

Authors:  Douglas W MacPherson; Militza Zencovich; Brian D Gushulak
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

9.  HIV-related travel restrictions: trends and country characteristics.

Authors:  Felicia Chang; Helen Prytherch; Robin C Nesbitt; Annelies Wilder-Smith
Journal:  Glob Health Action       Date:  2013-06-03       Impact factor: 2.640

Review 10.  HIV testing and counselling for migrant populations living in high-income countries: a systematic review.

Authors:  Debora Alvarez-del Arco; Susana Monge; Amaya Azcoaga; Isabel Rio; Victoria Hernando; Cristina Gonzalez; Belen Alejos; Ana Maria Caro; Santiago Perez-Cachafeiro; Oriana Ramirez-Rubio; Francisco Bolumar; Teymur Noori; Julia Del Amo
Journal:  Eur J Public Health       Date:  2012-09-23       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.